Last reviewed · How we verify
NCT04976985
Osteopathic Manipulative Treatment and Migraine Headaches
NA trial testing Osteopathic Manipulative Therapy (OMT) in Chronic Migraine in 140 participants. Status unknown.
30 March 2022
Quick facts
| Lead sponsor | St. Luke's Hospital, Pennsylvania |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 140 |
| Start date | 2 October 2018 |
| Primary completion | 30 March 2022 |
| Estimated completion | 30 March 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Osteopathic Manipulative Therapy (OMT)
- Standard of care
Conditions studied
- Chronic Migraine — all drugs for Chronic Migraine →
- Migraine Disorders — all drugs for Migraine Disorders →
- Headache Disorders — all drugs for Headache Disorders →
- Headache, Migraine — all drugs for Headache, Migraine →
Sponsor
St. Luke's Hospital, Pennsylvania
Who can join
Adults 18 to 50, any sex, with Chronic Migraine or Migraine Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study the investigators hypothesize, that Osteopathic Manipulative Therapy (OMT) will reduce migraine disability and severity scores when compared to standard of care including prophylactic pharmacological agents with treatment over 12 week time frame. The investigators aim to decrease severity and disability of migraine by utilizing Osteopathic Manipulative Therapy. This would ultimately reduce the utilization of office or emergency department visits, decrease the large economic burden the United States faces for migraine patients as well as improve quality of life for the 3 million chronic migraine patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04976985
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Osteopathic Manipulative Therapy (OMT)
Trials testing the same drug.
- NCT07497737 — OMT for Adhesive Capsulitis · Phase 4 · not yet recruiting
Other recruiting trials for Chronic Migraine
Currently open trials in the same condition.
- NCT06974617 — Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine · NA · recruiting
- NCT06684249 — Efficacy of Nerve Block Versus Botox in Chronic Migraine Management · NA · recruiting
- NCT05337033 — Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial · Phase 2 · recruiting
- NCT06625060 — A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults · Phase 2 · recruiting
- NCT06450444 — The RECLAIM Study. · NA · recruiting
Other St. Luke's Hospital, Pennsylvania trials
Trials by the same sponsor.
- NCT06029582 — VR Headset for Pain During Pregnancy Termination · NA · unknown
- NCT06806410 — The Efficacy of Liposomal Bupivacaine in Ultrasound Guided Supraclavicular Nerve Blocks for Hand and Wrist Surgery · Phase 4 · active not recruiting
- NCT05494645 — Exparel Use in Peripheral Nerve Blocks and Local Infiltration for Foot and Ankle Surgery: A Randomized Controlled Trial · Phase 4 · unknown
- NCT04910165 — Exparel Use in Adductor Canal Block After Total Knee Arthroplasty · Phase 3 · completed
- NCT03953404 — POC SPLA2-IIA as a Biomarker for Sepsis and Septic Shock · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04976985 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St. Luke's Hospital, Pennsylvania
- Last refreshed: 3 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04976985.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing